TAFI activity in coronary artery disease: a contribution to the current discussion on TAFI assays
Schroeder, V.; Wilmer, M.; Buehler, B.; Kohler, H.P.
Thrombosis and Haemostasis 96(2): 236-237
2006
ISSN/ISBN: 0340-6245 PMID: 16894472 Document Number: 598266
Document emailed within 1 workday
Related Documents
Ishii, H. 2004: Tafi Nihon Rinsho. Japanese Journal of Clinical Medicine 62 Suppl. 12: 717-719Kostka, H.; Kuhlisch, E.; Schellong, S.; Siegert, G. 2003: Polymorphisms in the TAFI Gene and the Risk of Venous Thrombosis Clinical Laboratory 49(11-12): 645-647
Brouwers, G-Jan.; Leebeek, F.W.G.; Tanck, M.W.T.; Wouter Jukema, J.; Kluft, C.; de Maat, M.P.M. 2003: Association between thrombin-activatable fibrinolysis inhibitor (TAFI) and clinical outcome in patients with unstable angina pectoris Thrombosis and Haemostasis 90(1): 92-100
Colucci, M.; Pentimone, A.; Binetti, B.M.; Cramarossa, M.; Piro, D.; Semeraro, N. 2002: Effect of heparin on TAFI-dependent inhibition of fibrinolysis: relative importance of TAFIa generated by clot-bound and fluid phase thrombin Thrombosis and Haemostasis 88(2): 282-287
Jovan P. Antovic 2003: Thrombin Activatable Fibrinolysis Inhibitor (TAFI) A Link between Coagulationand Fibrinolysis Clinical Laboratory 49(9-10): 475-486
Elbaz, M.; Fourcade, J.; Carrie, D.; Jean, M.; Karouny, E.; Foures, F.; Bery, E.; Bounhoure, J.P.; Puel, J. 1995: Coronary artery disease in octogenarians: contribution of coronary angiography and evaluation of therapeutic possibilities Archives des Maladies du Coeur et des Vaisseaux 88(10): 1391-1398
Levinson, S.S.; Hobbs, G.A. 1997: Optimized automated apolipoprotein A-I assays as markers for coronary artery disease Archives of Pathology and Laboratory Medicine 121(7): 678-684
Rahman, P.; Urowitz, M.B.; Gladman, D.D.; Bruce, I.N.; Genest, J. 1999: Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus Journal of Rheumatology 26(11): 2363-2368
Nikhilesh, J.; Sathyamurthy, I. 2005: Troponins: current status in coronary artery disease Journal of the Association of Physicians of India 53: 116-118
Halim, S.A.; Wang, A.; Harrison, J.K. 2011: Anomalous right coronary artery origin from the pulmonary artery (ARCAPA) coexisting with obstructive atherosclerotic disease of the left coronary artery Journal of Invasive Cardiology 23(1): E260-E261
Yu, J.; Han, J.; Mao, J.; Guo, L.; Gao, W. 2014: Association between serum uric acid level and the severity of coronary artery disease in patients with obstructive coronary artery disease Chinese Medical Journal 127(6): 1039-1045
Savchenko, A.P.; Akchurin, R.S.; Rudenko, B.A.; Shiriaev, A.A.; Cherkavskaia, O.V.; Kozlov, G.V. 2010: Long-term follow-up use of "cypher" sirolimus-eluting stents in patients with coronary heart disease after coronary artery bypass grafting with occlusive lesions of the coronary artery Vestnik Rentgenologii i Radiologii 4: 4-12
Jim, M.-H.; Siu, C.-W.; Ho, H.-H.; Miu, R.; Lee, S.W.-L. 2004: Anomalous origin of the right coronary artery from the left coronary sinus is associated with early development of coronary artery disease Journal of Invasive Cardiology 16(9): 466-468
Kucera, J. 1978: Congenital coronary artery defects and ischaemic disease of the myocardium. A population teratology contribution to the problem of myocardial infarction prevention Casopis Lekaru Ceskych 117(31): 945-949
Seyyed Mohammad Reza Kazemi-Bajestani; Ghayour, M.-Mobarhan; Ebrahimi, M.; Moohebati, M.; Habib-Esmaeili, A.; Gordon A. A. Ferns 2007: C-reactive Protein Associated with Coronary Artery Disease in Iranian Patients with Angiographically Defined Coronary Artery Disease Clinical Laboratory 53(1-2): 49-56
Wenger, N.Kass.; Helmy, T.; Patel, A.D.; Lerakis, S. 2005: Evidence-based management of coronary artery disease in the elderly--current perspectives Medgenmed: Medscape General Medicine 7(2): 75
Kowalski, M. 2001: Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. the detection of H. pylori specific DNA in human coronary atherosclerotic plaque Journal of Physiology and Pharmacology An Official Journal of the Polish Physiological Society 52(1 Suppl 1): 3-31
Sbraggia, P.; Habib, G.; Garcia, M.; Bonnet, J.L.; Ferracci, A.; Ambrosi, P.; Baille, Y.; Luccioni, R. 1996: Abnormal origin of the left coronary artery from the pulmonary artery. Diagnostic contribution of ultrasonographic technique Annales de Cardiologie et d'Angeiologie 45(9): 507-511
El-Jack, S.; Kerr, A. 2003: Secondary prevention in coronary artery disease patients in South Auckland: moving targets and the current treatment gap New Zealand Medical Journal 116(1185): U664
Kreuz, B.; Kiehl, H.; Kirsch, I.; Neumann, H.; Radoschewski, M.; Schmohl, M.; Schott, J. 1978: The contribution of social hygiene to the current obesity discussion in the German Democratic Republic. Part 1 Zeitschrift für Arztliche Fortbildung 72(9): 439-450